NO904218D0 - STABILIZED LEUKOCYTE INTERFERONES. - Google Patents

STABILIZED LEUKOCYTE INTERFERONES.

Info

Publication number
NO904218D0
NO904218D0 NO904218A NO904218A NO904218D0 NO 904218 D0 NO904218 D0 NO 904218D0 NO 904218 A NO904218 A NO 904218A NO 904218 A NO904218 A NO 904218A NO 904218 D0 NO904218 D0 NO 904218D0
Authority
NO
Norway
Prior art keywords
interferones
leukocyte
stabilized
stabilized leukocyte
leukocyte interferones
Prior art date
Application number
NO904218A
Other languages
Norwegian (no)
Other versions
NO904218L (en
Inventor
Alberto Ferro
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO904218D0 publication Critical patent/NO904218D0/en
Publication of NO904218L publication Critical patent/NO904218L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO90904218A 1989-09-28 1990-09-27 STABILIZED LEUKOCYTE INTERFERONES. NO904218L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (2)

Publication Number Publication Date
NO904218D0 true NO904218D0 (en) 1990-09-27
NO904218L NO904218L (en) 1991-04-02

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904218A NO904218L (en) 1989-09-28 1990-09-27 STABILIZED LEUKOCYTE INTERFERONES.

Country Status (26)

Country Link
EP (1) EP0420049B1 (en)
JP (1) JPH03130232A (en)
KR (1) KR910005886A (en)
CN (1) CN1050503A (en)
AR (1) AR244551A1 (en)
AT (1) ATE92334T1 (en)
AU (1) AU636653B2 (en)
CA (1) CA2024046A1 (en)
CZ (1) CZ277712B6 (en)
DD (1) DD298054A5 (en)
DE (1) DE59002183D1 (en)
FI (1) FI904756A0 (en)
HU (1) HU205555B (en)
IE (1) IE903479A1 (en)
IL (1) IL95769A0 (en)
IS (1) IS3631A7 (en)
MC (1) MC2149A1 (en)
MX (1) MX22522A (en)
MY (1) MY106615A (en)
NO (1) NO904218L (en)
NZ (1) NZ235153A (en)
PH (1) PH27531A (en)
PT (1) PT95454A (en)
RU (1) RU2008017C1 (en)
YU (1) YU184090A (en)
ZA (1) ZA907579B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6794194A (en) * 1993-05-18 1994-12-20 Bukh Meditec A/S A method for the preparation of interferons
WO1997041885A1 (en) * 1996-05-09 1997-11-13 Feronpatent Limited Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
JP2001526662A (en) * 1997-05-09 2001-12-18 フェロンパテント リミテッド Stabilization of interferon in aqueous solution for the production of sublingual tablets
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
EP1066059B1 (en) * 1998-03-26 2005-06-15 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
CN1175901C (en) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 Stable water solution of interferon
BRPI0513332A (en) 2004-08-12 2008-05-06 Schering Corp stable pegylated interferon formulation
DE102004048379A1 (en) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Spring element made of sputtered shape memory alloy
CU23432B6 (en) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (en) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd Purifying method of interferon
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
DE3467706D1 (en) * 1983-04-28 1988-01-07 Armour Pharma Pharmaceutical preparation containing purified fibronectin
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
TNSN86042A1 (en) * 1985-03-25 1990-01-01 Schering Corp STABLE COMPOSITIONS BASED ON INTERFEREON - GAMMA
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
HUT56284A (en) 1991-08-28
MY106615A (en) 1995-06-30
FI904756A0 (en) 1990-09-27
CA2024046A1 (en) 1991-03-29
EP0420049A1 (en) 1991-04-03
MX22522A (en) 1993-10-01
CN1050503A (en) 1991-04-10
AU6309890A (en) 1991-04-11
IE903479A1 (en) 1991-04-10
ZA907579B (en) 1991-06-26
YU184090A (en) 1992-09-07
HU906021D0 (en) 1991-03-28
CZ277712B6 (en) 1993-03-17
JPH03130232A (en) 1991-06-04
DE59002183D1 (en) 1993-09-09
DD298054A5 (en) 1992-02-06
AU636653B2 (en) 1993-05-06
NZ235153A (en) 1993-03-26
RU2008017C1 (en) 1994-02-28
PH27531A (en) 1993-08-18
IS3631A7 (en) 1991-03-29
ATE92334T1 (en) 1993-08-15
KR910005886A (en) 1991-04-27
IL95769A0 (en) 1991-06-30
AR244551A1 (en) 1993-11-30
HU205555B (en) 1992-05-28
NO904218L (en) 1991-04-02
CS432890A3 (en) 1992-12-16
MC2149A1 (en) 1992-03-10
PT95454A (en) 1991-05-22
EP0420049B1 (en) 1993-08-04

Similar Documents

Publication Publication Date Title
FI902339A0 (en) PARFYMPARTIKLAR FOER ANVAENDNING I RENGOERINGS- OCH BEHANDLINGSKOMPOSITIONER.
FI901329A0 (en) BANFORMNINGSVIRA FOER VAOTPARTIET I EN PAPPERSMASKIN.
FI902181A0 (en) PAOFYLLNINGS / TOEMNINGSANORDNING FOER EN ANGIOPLASTISK KATETER INNEHAOLLANDE EN I STOMMEN INSTALLERAD DIGITALISK VISNING.
FI890803A0 (en) INMATNINGSSYSTEM FOER BRAENNLUFT I EN AOTERVINNINGSPANNA.
DE69018278D1 (en) Cryopump.
FI902395A0 (en) FOERFARANDE FOER KONTINUERLIG FAERGAENDRNING I SPRAYFAERGNING.
DE69006276D1 (en) Funding.
DE59009679D1 (en) Subrack.
NO904218D0 (en) STABILIZED LEUKOCYTE INTERFERONES.
FI891419A (en) ANORDNING I EN GAENGOEPPNINGSANORDNING FOER BORRMASKINERI.
DE69000268D1 (en) STABILIZED ANTI-MEDIUM.
FI891719A0 (en) ROERSYSTEM FOER LUFTFOERDELNING I PAPPERSMASKIN.
DE59008119D1 (en) Subrack.
FI891188A0 (en) FOERPACKNING FOER KOMPONENTER I EN ROERLEDNING.
FI894702A (en) FOERFARANDE I BEHANDLINGSANLAEGGNING FOER GLASSKIVOR.
FI891147A0 (en) VAERMNINGS- OCH AVFROSTNINGSSYSTEM FOER UNDERREDET I LARVBANDMASKINER.
FI890091A (en) I BILENS ELKRETS ANSLUTNINGSBAR UPPVINDNINGSANORDNING FOER ELLEDNING.
FI890255A (en) LYFTARE FOER INNERTAKSSKIVOR I BYGGNADER.
FI892215A0 (en) FOERRAODSMODUL I FOERRAODSUTRYMMEN FOER BOSTADSANVAENDARES PERSONLIGA BRUK.
FI892516A (en) I KOEKSSKAOP ANBRINGBART GLIDLAODSYSTEM.
FI892694A (en) SKYDDSPARTIER I EN SKYDDSKO.
FI893996A0 (en) ANORDNING I EN PAPPERSMASKIN.
FI894385A (en) AONGPANNEENHET I SYNNERHET FOER VINTERBRUK.
FI894920A0 (en) STABILIZERINGANORDNING FOER DRAGARMARNA I EN TRAKTOR.
FI895476A (en) TILLVAEXTUNDERLAGSKAERL FOER ANVAENDNING I TEMPERATURGRADIENTSINKUBATOR.